 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
February 18, 2010
IsoRay
Richland-based IsoRay hired William Cavanagh as vice president of research and development for IsoRay Medical. Cavanagh was chief scientific officer for Sangretech Biomedical for six years, overseeing design and use of a novel cancer therapy. IsoRay is a medical isotope company focusing on the treatment of prostate cancer and other malignant diseases.